Fluidic platforms for perfusable vascularized tissues with infiltrates
Microfluidic devices with open ports and gel channels for forming perfusable hydrogel vascular networks with holes or ports for samples, and methods of making and using, are provided which integrate interstitial flows to an ex vivo vascularized tissue model. Samples of cells, spheroids, organoids, and tissues can be used for screening of agents for efficacy, toxicity and dosage. The devices create interstitial flow from the top of the gel hole, through the sample toward the vascular networks, and/or luminal flows generated by a pressure difference between two media channels across the vascular network. This system is useful for studying angiogenesis, immune cell migration and testing new immunotherapy drug candidates.
1 . A microfluidic device for forming perfusable tissue masses with infiltrates, the microfluidic device comprising:
a) adjacent and parallel microchannels comprising
at least one central microchannel as a gel channel and at least two microchannels as media channels,
wherein the gel channel is sandwiched between the media channels,
wherein the gel channel comprises a first end and a second end and is separated from the media channels by phase guides; and
b) at least one open-top port positioned in a top surface of the gel channel and at a distance away from the first end and the second end;
wherein the gel channel comprises a perfusable microvascular network having an interconnected network of channels lined by endothelial cells that are surrounded by a gel,
wherein the gel comprises at least one cavity in the gel for implanting an extracellular matrix and one or more cells, spheroids, organoids, or mixes of cells therein,
wherein the interconnected network of channels of the perfusable microvascular network surround the at least one cavity and allow for extravasation of cellular components from a cell culture media flowed therein to the one or more cells, spheroids, organoids, or mixes of cells therein,
wherein the at least one cavity is positioned below the at least one open-top port.
2 . The microfluidic device of claim 1 , wherein the at least one open-top port has a diameter between about 0.5 to 2 mm.
3 . The microfluidic device of claim 1 , wherein the gel channel and the media channels have a height of about 200-500 μm.
4 . The microfluidic device of claim 3 , wherein the gel channel has a length measured from the first end to the second end between about 10 mm and 50 mm.
5 . The microfluidic device of claim 1 , wherein the at least one open-top port is positioned at about a center of the gel channel.
6 . The microfluidic device of claim 1 , wherein the at least one open-top port is positioned at a distance between about 1 mm and about 20 mm away from the first end and the second end of the gel channel.
7 . The microfluidic device of claim 1 , wherein each open-top port includes a removable spacer.
8 . The microfluidic device of claim 1 , wherein the first end and the second end of the gel channel are open ends.
9 . The microfluidic device of claim 1 further comprising fluidic connections to generate flows of a cell culture media through the interconnected network of channels in the gel inside the gel channel.
10 . The microfluidic device of claim 1 wherein the interconnected network of channels are microvessels of about 5-100 μm in diameter and 50-200 μm in length, and wherein a monolayer of the endothelial cells coats the channels of the interconnected network,
wherein the gel in the gel channel further comprises extracellular matrix (ECM) components.
11 . The microfluidic device of claim 10 , wherein the microvascular network further comprises cells selected from the group consisting of stromal cells, smooth muscle cells, pericytes, fibroblasts, progenitor cells, astrocytes, adipocytes, neural cells, stem cells and combinations thereof.
12 . The microfluidic device of claim 10 , wherein the extracellular matrix components are selected from the group consisting of collagen, fibrin, fibronectin, elastins, laminin, hyaluronic acid; vitronectin, D-lysine, proteoglycans, and combinations thereof.
13 . The microfluidic device of claim 1 , further comprising media for freezing cells.
14 . The microfluidic device of claim 1 , wherein the cellular components comprise immune cells isolated from blood selected from the group consisting of T-cells, monocytes, natural killer cells, neutrophils, B-cells, and cell lines thereof.
15 . A microfluidic platform comprising a plurality of microfluidic devices of claim 1 .
16 . The microfluidic device of claim 15 further comprising fluidic connections contacting the at least one open-top port and/or at least one of the media channels.
17 . The microfluidic platform of claim 16 wherein the at least one open-top port positioned over the at least one cavity of each microfluidic device is connected to a fluidic pipeline to generate a fluid flow and horizontally through the gel channel.
18 . The microfluidic platform of claim 17 wherein the fluid flow flows vertically and horizontally through the gel channel of each microfluidic device and towards at least one of the media channels of each microfluidic device.
19 . The microfluidic device of claim 18 , wherein the fluid flow comprises interstitial and luminal flows.
20 . The microfluidic platform of claim 17 wherein the fluid flow has a flow rate between 0.001 and 10 μl/s.
21 . A method of forming perfusable tissue masses optionally with cellular infiltrates in the microfluidic device of claim 1 , comprising the steps of:
i) depositing one or more cells, spheroids, organoids, or mixes of cells into the at least one cavity; and
ii) flowing a cell culture media within the perfusable microvascular network to extravasate cellular components in the cell culture media to the one or more cells, spheroids, organoids, or mixes of cells.
22 . The method of claim 21 , wherein the one or more cells, spheroids, organoids, or mixes of cells are in a supporting extracellular matrix.
23 . The method of claim 21 , wherein at least one of the media channels comprises additional cells for infiltrating the perfused one or more cells, spheroids, organoids, or mixes of cells.
24 . The method of claim 21 further comprising culturing the one or more cells, spheroids, organoids, or mixes of cells in the microfluidic device for a period between about 2 and 10 days.
25 . A method of freezing the microfluidic device of claim 13 comprising placing the microfluidic device at 4° C. for 1 to 4 hours then at −80° C. for 8-12 hours.
26 . The method of claim 25 , further comprising thawing the microfluidic device at 37° C. and perfusing it with media to revive the cells inside the microfluidic device.